MESOTHELIAL LESIONS OF THE PERITONEUM

Size: px
Start display at page:

Download "MESOTHELIAL LESIONS OF THE PERITONEUM"

Transcription

1 1 MESOTHELIAL LESIONS OF THE PERITONEUM Philip B. Clement, MD Departments of Pathology, Vancouver General Hospital and the University of British Columbia

2 2 Mesothelial lesions are commonly encountered by pathologists dealing with gynecologic, peritoneal, omentectomy, and even lymphadectomy specimens. Fortunately, the mesothelial nature of the process is usually suggested by its location and lesional cells that retain a resemblance to normal mesothelial cells. Additionally, there are a variety of immunostains that can facilitate the differential diagnosis with an epithelial process, most commonly a serous tumor. However, within the spectrum of mesothelial lesions, the distinction between hyperplastic versus neoplastic, and between benign versus malignant, can sometimes be challenging. Although adenomatoid tumors are tumors of mesothelial origin, they are found, enigmatically, almost exclusively, in the genital tract, and will therefore not be considered further here. MESOTHELIAL HYPERPLASIA This lesion is a common response to chronic ascites, inflammation (such as pelvic inflammatory disease), operations, endometriosis, ovarian tumors, and metastatic tumors. Mesothelial hyperplasia confined to a hernia sac may reflect trauma or incarceration. Solitary or multiple small nodules may be visible at operation, but more commonly the process is an incidental microscopic finding. The hyperplastic mesothelial cells are usually confined to the peritoneal surface in the form of nodules, plaques, or papillae. In occasional cases, however, small nests, trabeculae, tubules, papillae, or even single cells can become entrapped in reactive fibrous tissue or extend superficially into underlying tissues, including the walls of ovarian tumors, endometriotic cysts, and peritoneal inclusion cysts ( mural mesothelial proliferation ). This finding can have a worrisome infiltrative appearance that can sometimes be mistaken for invasive tumor. A clue to the correct diagnosis in such cases is that the hyperplastic mesothelial cells are often focally disposed within the tissue in linear, sometimes parallel, arrangements; also the cells are in continuity with the serosa rather than, in the instance of an ovarian tumor, the obviously neoplastic cells of the ovarian tumor. We have also seen cases of mesothelial hyperplasia on the surface of an ovarian tumor that have been misdiagnosed as serosal involvement by tumor, an error that would result in assignment of a stage of Ic rather than Ia. The hyperplastic mesothelial cells resemble normal mesothelial cells, being usually cuboidal with eosinophilic cytoplasm; the latter may contain vacuoles that stain for acid mucin (predominantly hyaluronic acid) but not for neutral (PASD+) mucin. There is usually only mild or occasionally moderate nuclear pleomorphism; multinucleated cells and occasional mitotic figures may be seen. Uncommon findings include psammoma bodies and eosinophilic strap-shaped cells resembling rhabdomyoblasts. In some cases, histiocytes may be admixed with the mesothelial cells, and may predominate in some cases. Rarely, hyperplastic mesothelial cells can be found as an incidental finding in abdominopelvic lymph nodes where they may be misinterpreted as metastatic tumor. There is usually comcomitant mesothelial hyperplasia of the pelvic and/or abdominal peritoneum. The cells may form nests or papillary clusters within the sinusoids of the lymph node; in some cases the appearance is similar to that of sinus histiocytosis. The appearance of the cells on routine stains suggests the correct diagnosis, although distinction of the process from a metastatic serous borderline tumor can be difficult. If necessary, metastatic

3 3 borderline tumor or carcinoma can be excluded with mucin and immunohistochemical stains (see page 9). If misdiagnosis of the process occurs in a woman with a known primary pelvic cancer, it could result in inappropriate staging and treatment, or in a different setting, could precipitate a fruitless search for an occult primary tumor. Differential Diagnosis 1. Peritoneal malignant mesothelioma (PMM). Features that favor or indicate PMM include grossly visible nodules, deep infiltration, necrosis, a diffuse uniform tubulopapillary pattern, large "empty" cytoplasmic vacuoles, marked nuclear atypia, and atypical mitotic figures. Some of these features, however, such as marked nuclear atypia, may be absent or present only focally within a PMM. Although immunroeactivity for p53 and/or EMA favors PMM and desmin positivity favors hyperplasia, immunofindings cannot be relied upon to assist in this differential diagnosis in an individual case. 2. Serous borderline tumors (BSTs) of primary peritoneal or ovarian origin. Grossly visible ovarian or peritoneal tumor, columnar cells with or without cilia, neutral mucin, numerous psammoma bodies, and immunohistochemical markers for epithelial differentiation (page 9) all favor or indicate a BST. References 1. Chan JKC, Loo KT, Yau BKC, Lam SY. Nodular histiocytic/mesothelial hyperplasia: A lesion potentially mistaken for a neoplasm in transbronchial biopsy. Am J Surg Pathol 21:658-63, Churg AC et al. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 24: , Clement PB, Young RH. Florid mesothelial hyperplasia associated with ovarian tumors: A possible source of error in tumor diagnosis and staging. Int J Gynecol Pathol 12:51-58, Clement PB, Young RH, Oliva E, Sumner HW, Scully RE. Hyperplastic mesothelial cells within abdominal lymph nodes: A mimic of metastatic ovarian carcinoma and serous borderline tumor. Mod Pathol 9:879-86, Gupta A, Bhan AK, Bell DA. Can the implants of serous borderline tumors of the ovary be distinguished from mesothelial proliferations by the use of immunohistochemistry? Abstract. Mod Pathol 16:10A, Davidson B, Nielsen S, Christensen J et al. The role of desmin and N-cadherin in effusion cytology. Am J Surg Pathol 25: , Henderson DW, Shilkin KB, Whitaker D. Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ. Am J Clin Pathol 110: , 1998

4 4 8. Kerner H, Gaton E, Czernobilsky B. Unusual ovarian, tubal and pelvic mesothelial inclusions in patients with endometriosis. Histopathology 5: , McCaughey WTE, Al-Jabi M. Differentiation of serosal hyperplasia and neoplasia in biopsies. Pathol Annu 21(1): , Rosai J, Dehner LP. Nodular mesothelial hyperplasia in hernia sacs. A benign reactive condition stimulating a neoplastic process. Cancer 35: , 1975 PERITONEAL INCLUSION CYSTS Peritoneal inclusion cysts (PICs) typically occur in women of reproductive age; rarely the lesions occur in males and in the pleural cavity. They may be unilocular or multilocular. UNILOCULAR PICS Unilocular PICs are usually an incidental intraoperative finding. Single or multiple, small, thin-walled, translucent, unilocular cysts are attached or free-floating. The cysts have a smooth lining, yellow and watery to gelatinous contents, and a lining composed of a single layer of flattened, benign mesothelial cells. Most unilocular PICs are probably reactive, whereas some of those in the mesocolon, mesentery of the small intestine, retroperitoneum, and splenic capsule may be developmental. MULTILOCULAR PICS (MPICS) We prefer the designation multiolocular peritoneal inclusion cyst (MPIC) for this lesion, but it is also commonly referred to as "benign cystic mesothelioma, and in the older ltierature, "inflammatory peritoneal cyst" and "postoperative peritoneal cyst" were also used. In contrast to unilocular PICs, MPICs, which may reach 20 cm in maximal dimension, are usually associated with clinical manifestations, most commonly lower abdominal pain, a palpable mass, or both. MPICs are usually adherent to pelvic organs. MPICs may mimic a cystic ovarian tumor on clinical examination, at laparotomy, or even on pathological examination, especially if adherent to an ovary. The upper abdominal cavity, the retroperitoneum, or a hernia sac may also be involved. Unlike unilocular PICs, the septa and walls of MPICs may contain considerable amounts of fibrous tissue. Their contents may resemble those of the unilocular cysts or be serosanguineous or bloody. MPICs are typically lined by a single layer of flat to cuboidal, occasionally hobnail-shaped, mesothelial cells with nuclear features that vary from bland to mildly atypical. Unusual findings include squamous metaplasia, intracystic papillae or sheets of mesothelial cells, cribriform patterns, and mural proliferations of typical or atypical mesothelial cells arranged singly, as gland-like structures or nests, or in patterns resembling those in adenomatoid tumors. Occasional vacuolated mesothelial cells in the stroma may simulate signet-ring cells. The septa typically consist of fibrovascular connective tissue, but occasionally contain a striking acute and chronic cell infiltrate, abundant fibrin, granulation tissue, and evidence of recent and remote hemorrhage. One MPIC had a prominent xanthogranulomatous inflammatory reaction in its walls. Occasional MPICs are immunoreactive for estrogen receptors, progesterone receptors, or both.

5 5 A history of a prior abdominal operation, pelvic inflammatory disease, or endometriosis can be found in as many as 84% of patients, suggesting a role for inflammation in the pathogenesis of the cysts. In cases that we consider MPICs, follow-up has not disclosed malignant behavior. In as many as one-half of the cases, however, the MPICs have recurred from months to many years postoperatively, but at least some of these "recurrences" are likely the result of new postoperative adhesions. GnRH-agonists and/or tamoxifen, both of which induce a hypoestrogenic state, have successfully reduced the size of unresectable recurrent MPICs. Differential Diagnosis of MPICs 1. Multilocular cystic lymphangiomas. In contrast to MPICs, these lesions typically occur in children (especially boys), are usually extrapelvic (mesentery of the small intestine, omentum, mesocolon or retroperitoneum), contain chylous fluid, have mural lymphoid aggregates and smooth muscle, and lining cells that are immunoreactive for endothelial markers 2. Multicystic adenomatoid tumor. In contrast to MPICs, these tumors typically involve the myometrium, contain foci of typical adenomatoid tumor, and lack prominent numbers of inflammatory cells. References 1. Brustmann H. Multilocular peritoneal inclusion cyst with extensive xanthogranulomatous stromal changes: A differential diagnosis of cystic pelvic tumors in women. Ann Diagn Pathol 2000;4: Carpenter HA, Lancaster JR, Lee RA. Multilocular cysts of the peritoneum. Mayo Clin Proc 57: , Letterie GS, Yon JL. The antiestrogen tamoxifen in the treatment of recurrent benign cystic mesothelioma. Gynecol Oncol 70:131-3, McFadden DE, Clement PB. Peritoneal inclusion cysts with mural mesothelial proliferation. A clinicopathological analysis of six cases. Am J Surg Pathol 10: , Ross MJ, Welch WR, Scully RE. Multilocular peritoneal inclusion cysts (so-called cystic mesotheliomas). Cancer 64: , Sawh RN, Malpica A, Deavers MT, et al. Benign cystic mesothelioma of the peritoneum: A clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status. Hum Pathol 34:369-74, Weiss SW, Tavassoli FA. Multicystic mesothelioma: An analysis of pathologic findings and biologic behavior in 37 cases. Am J Surg Pathol 12: , 1988

6 6 WELL-DIFFERENTIATED PAPILLARY MESOTHELIOMA These peritoneal lesions (WDPMs) are uncommon. Eighty percent of them have occurred in females, who are usually of reproductive age but occasionally postmenopausal. WDPMs are usually an incidental finding at laparotomy but rare tumors have been associated with abdominal pain or ascites. Occasional patients have had asbestos exposure (Butnor). WDPMs are solitary or more often multiple, and are usually grey to white, firm, papillary or nodular lesions <2 cm in maximal size. The omental and pelvic (including ovarian) peritoneum is typically involved, or rarely, the gastric, intestinal, or mesenteric peritoneum. In contrast to malignant mesotheliomas, orderly fibrous papillae are lined by a single layer of flattened to cuboidal mesothelial cells with occasional basal vacuoles and benign nuclear features. Mitotic figures are rare or absent. Uncommon patterns include tubulopapillary, adenomatoid-like areas, branching cords, and solid sheets. The stroma may be extensively fibrotic. Multinucleated stromal giant cells and/or psammoma bodies are encountered in occasional cases. Follow-up studies indicate that solitary WDPMs are usually clinically benign; occasional tumors have persisted for decades. One solitary apparently typical WDPM of the peritoneum in a 34-year-old male progressed and was fatal at 3 years (Butnor). When multiple tumors are present, they should each be removed for microscopic examination because Goldblum & Hart have shown that lesions with the appearance of a WDPM may be associated with other lesions that have the appearance of a malignant mesothelioma and progressive disease on follow-up. The behavior of multiple WDPMs has been indolent in some cases, but caes of this type have not been studied in sufficient numbers with prolonged follow-up to be certain of their behavior. References 1. Butnor KJ, Sporn TA, Hammar SP, Roggli VL. Well-differentiated papillary mesothelioma. Am J Surg Pathol 25:1304-9, Daya D, McCaughey WTE. Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases. Cancer 65: , Goldblum, J, Hart WR. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathological study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas and localized fibrous tumors. Am J Surg Pathol 19: , Sant'Ambrogio S, Malpica A, Deavers MT, Ordonez NG, Silva EG. Well differentiated papillary and malignant mesothelioma of the peritoneum in women. Abstract. Mod Pathol 13:131A, 2000.

7 7 MALIGNANT MESOTHELIOMA Clinical Features Malignant mesotheliomas of the peritoneal cavity (PMMs) account for only 10% to 20% of all mesotheliomas, and in women are much less common than peritoneal papillary serous carcinomas. Two-thirds of patients with PMMs are male, although because of the rarity of pleural mesotheliomas in women, the ratio of peritoneal to pleural mesotheliomas is higher in women (1:2) than in men (1:5). The affected patients are usually middle-aged or elderly, but occasionally PMMs occur in young adults and children. The age range in the largest series of PMMs in women was 18 to 92 (mean, 49) years (Baker). The presenting manifestations are usually nonspecific, including abdominal discomfort and distension, digestive disturbances, and weight loss. Ascites is present in the majority of cases, and cytologic examination of the ascitic fluid may be diagnostic. Occasionally the tumor is more localized, such as within a hernia or hydrocele sac, or takes the form of a retroperitoneal, umbilical, intestinal, or pelvic tumor, or as cervical or inguinal lymphadenopathy. Prominent ovarian involvement in rare cases may result in an intraoperative appearance that mimics a primary ovarian tumor with peritoneal spread. Rare otherwise typical PMMs have been confined to the ovary, likely representing a primary ovarian malignant mesothelioma. Rarely, PMMs may present as a localized acute inflammatory lesion without an obvious mass, intraoperatively mimicking acute appendicitis or cholecystitis. Some PMMs may be an unexpected microscopic finding. For example, we recently encountered a case in whch a woman underwent laparotomy for intractable ascites. No obvious lesions were identified intraoperatively, but a PMM was found on microscopic examination of the omentectomy specimen. Over 80% of the patients with PMM in one series (Kannerstein & Churg) had a history of asbestos exposure, but most of these patients were men who were identified because of an occupational exposure to asbestos. In contrast, three recent series of PMMs in women found no definite association with a history of asbestos exposure (Goldblum, Kerrigan, Baker). Although asbestos fibers have been identified with special techniques in some of these women, it appears that a high occupational exposure to asbestos, specifically amphiboles (amosite and crocidolite), is required to induce a malignant mesothelioma. In cases lacking such a history, other etiologic factors such as radiation, chronic inflammation, organic chemicals, and nonasbestos mineral fibers may play a role. Most males with PMMs that have been reported in the literature survived <2 years after diagnosis, although there are occasional long-term survivors. Kerrigan et al, however, found in a recent study that approximately 40% of women with PMMs have a relatively indolent course, with survival for 4 years, and in some cases, for >10 years. None of the patients who survived 4 years had died of disease at the time of their last follow-up. No significant differences in the histology of the tumors with short survival compared to those with long survival were found. Pathological Findings The visceral and parietal peritoneum is usually diffusely thickened by nodules and plaques. The viscera are often encased by tumor, but visceral invasion and lymphatic and

8 8 hematogenous spread are less common than in carcinomas with comparable degrees of peritoneal involvement. Some tumors incite a striking desmoplastic reaction. As noted above, rare PMMs form localized solitary masses or present as an inflammatory lesion without an obvious tumor mass. Most PMMs are of epithelial type; biphasic and sarcomatoid tumors are much less common than in the pleura. For example, in the largest study of PMMs in women (Baker), 94% were of epithelial type, with only 6% being biphasic or sarcomatoid. In contrast, the frequency of biphasic and sarcomatoid pleural tumors in one study was 45% (Legha & Muggia). In epithelial PMMs, the tumor cells are arranged in tubular, papillary, and solid patterns, usually admixed; areas of necrosis may be present. There is usually evidence of invasion of subperitoneal tissues, such as the omentum. As noted above, intra- and extraabdominal lymph nodes may be involved. The tumor cells usually retain some resemblance to mesothelial cells, with a cuboidal shape and eosinophilic cytoplasm. Usually there is mild to moderate nuclear atypicality and variably prominent nucleoli; sever atypia can occur but is uncommon. Mitotic figures are usually present, but are rarely numerous. Uncommon patterns and cell types in mesotheliomas can complicate the differential diagnosis. In at least some of these cases, however, the focal presence of the characteristic tubulopapillary pattern and tumor cells resembling mesothelial cells will facilitate the differential diagnosis. Rare tumors have an exclusively solid pattern of polygonal cells with abundant eosinophilic glassy cytoplasm and prominent nucleoli ("deciduoid" PMMs). This pattern, based on a small number of cases, appears to be more common in the peritoneum of adolescent females or young adult women, although similar tumors in males and in the pleura have been recently reported. The prominent nucleoli, often brisk mitotic activity, and immunoreactivity of the tumors cells for cytokeratin exclude an ectopic decidual reaction. A deciduoid mesothelioma with prominent ovarian involvement could bring into the differential diagnosis a broad group of ovarian tumors with oxyphilic cells, as covered in detail elsewhere (Young & Scully). Similarly, rare peritoneal mesotheliomas focally have insular, trabecular, tubular, and retiform patterns, and even cells with nulcear gorooves, potentially mimicking a sex cord-stromal tumor. As already noted, biphasic and purely sarcomatous mesotheliomas are rare in the peitoneum, but several biphasic mesotheliomas have had prominent ovarian involvement, tumors that may be potentially confused with an ovarian malignant mixed mesodermal tumor. The epithelial components of biphasic mesotheliomas usually resemble pure epithelial mesotheliomas, contrasting with the high-grade mullerian-type carcinomatous component of the typical MMMT. Heterologous sarcomatous elements can occur in both biphasic mesotheliomas and MMMTs, and thus their presence is not diagnostically helpful. Rare peritoneal mesotheliomas, one of which involved the ovaries (Kitazawa), have abundant foamy cytoplasm due to lipid within the tumor cells. Solid patterns in such tumors with ovarian involvement could lead to possible confusion with lipid-rich ovarian tumors such as steroid cell tumors. Minor foci of cells with clear cytoplasm are common in peritoneal mesotheliomas, and rarely they can be prominent. The presence of clear cells, especially if accompanied by hobnail cells and hyalinized papillae (a frequent finding), could raise a differential diagnosis with a clear cell carcinoma. In such cases, the absence of the typical tubulocystic pattern of clear cell carcinoma, relative blandness of nuclear features in

9 9 mesotheliomas compared to clear cell carcinomas, and the different immunohistochemical features of the two tumors will resolve the diagnostic problem. Occasional PMMs have a stiking myxoid stroma or a striking desmoplastic stroma, although the latter is more rare in our experience. Other tumors contain a prominent inflammatory infiltrate, which may include a dense lymphocytic infiltrate with lymphoid follicles, granulomas, or numerous foamy lipid-rich histiocytes ("lymphohistiocytoid mesotheliomas"). The histochemical and immunohistochemical features of PMMs are indicated below. Differential Diagnosis Some differential diagnostic considerations raised by uncommon patterns in PMMs have been alaready discussed. The differential diagnosis of typical PMMs uncludes: 1. Atypical mesothelial hyperplasia (page 3). 2. Well differentiated papillary mesothelioma (page 6). 3. Adenocarcinoma with diffuse peritoneal involvement, including metastatic adenocarcinomas and adenocarcinomas of primary peritoneal origin. Features favoring a diagnosis of PMM include a prominent tubulopapillary pattern, polygonal cells with moderate amounts of eosinophilic cytoplasm, only mild to moderate nuclear atypia, a paucity of mitotic figures, and the presence of acid mucin (alcianophilic material) rather than neutral (PAS+) mucin. PMMs usually lack immunoreactivity for a variety of "epithelial" antigens, including B72.3, Leu-M1 (CD15), Ber-EP4, CEA, CA19-9, S-100 protein, and placental alkaline phosphatase. Of these, Ber-EP4, B72.3, Leu-M1 (CD15), MOC-31, and CA19-9 are the most useful in the differential with primary peritoneal serous carcinoma. Antigens that are usually present in epithelial PMMs but not primary peritoneal serous carcinomas are cytokeratin 5/6, thrombomodulin, and calretinin. No single immunohistochemical stain is diagnostic in the separation of PMM from adenocarcinoma, and the results of a panel of antibodies should be interpreted in conjunction with the H&E and mucin stains. 4. Malignant vascular tumors of the peritoneum. Lin et al reported peritoneal epithelioid hemangioendotheliomas or epithelioid angiosarcomas that mimicked PMM. Features that suggested the diagnosis of PMM in some cases included epithelioid cells in a tubulopapillary pattern and the presence of reactive or neoplastic spindle cells resulting in a focal biphasic pattern. Variable degrees of vascular differentiation and immunoreactivity of the neoplastic cells for endothelial antigens (and negative or weak cytokeratin staining) excluded the diagnosis of PMM. 5. Reactive fibrosis (vs desmoplastic PMM). Features favoring or indicating PMM include nuclear atypia, necrosis, organized patterns of collagen deposition (fascicular, storiform), frankly sarcomatoid areas, and infiltration of adjacent tissues.

10 10 References 1. Attanoos RL, Griffin A, Gibbs AR. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use of desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived grwoth factorreceptor, P-glycoprotein and Bcl-2. Histopathology 2003;43: Attanoos R, Webb R, Dojcinov SD, Gibbs AR. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology 2002;40: Attanoos R, Webb R, Dojcinov SD, Gibbs AR. Malignant epithelioid mesothelioma: Antimesothelial marker expression correlates with histologic pattern. Histopathology 2001;39: Baker PM, Clement PB, Young RH. Malignant mesotheliomas of the peritoenum in women. A study of 75 cases with emphasis on their morphological spectrum and differential diagnosis (submitted for publication). 5. Clement PB, Young RH, Scully RE. Malignant mesotheliomas presenting as ovarian masses. Am J Surg Pathol 20: , Goldblum, J, Hart WR. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathological study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas and localized fibrous tumors. Am J Surg, Pathol 19: , Heller DS, Gordon RE, Clement PB, Turnnir R, Katz N. Presence of asbestos in peritoneal mesotheliomas in women. Int J Gynecol Cancer 1999;9: Kannerstein M, Churg J. Peritoneal mesothelioma. Hum Pathol 8:83-94, Kerrigan SAJ, Cagle P, Churg A. Malignant mesothelioma of the peritoneum presenting as an inflammatory mass. Am J Surg Pathol 2003;27: Kerrigan SAJ, Turnnir RT, Clement PB, Young RH, Churg A. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: A clinicopathologic study of 25 cases. Cancer 2002;94: Khoury N, Raju U, Crissman JD, Zarbo RJ, Greenawald KA. A comparative immunohistochemical study of peritoneal and ovarian serous tumors, and mesotheliomas. Hum Pathol 21: , Kitizawa M, Kaneko H, Toshima M, Ishikawa H, Kobayashi H, Sekiya M. Malignant peritoneal mesothelioma with massive foamy cells. Codfish roe-like mesothelioma. Acta Pathol Jpn 1984;34: Legha SS, Muggia FM. Pleural mesothelioma: clinical featuers and theraepeutic implications. Ann Intern Med 1977;87:

11 Lin BT-Y, Colby T, Gown AM, Hammar SP, Mertens RB, Churg A, Battifora H. Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases. Am J Surg Pathol 20: , McCaughey WTE, Colby TV, Battifora H et al. Diagnosis of diffuse malignant mesothelioma: Experience of a US/Canadian mesothelioma panel. Mod Pathol 4: , Nascimento AG, Keeney GL, Fletcher CDM. Deciduoid peritoneal mesothelioma. An unusual phenotype affecting young females. Am J Surg Pathol 18: , Ordonez NG. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Am J Surg Pathol 22: , Roggli VL, Oury TD, Moffatt EJ. Malignant mesothelioma in women. Anatomic Pathology 2:147-63, Shanks JH, Harris M, Banerjee SS et al. Mesotheliomas with deciduoid morphology. A morphologic spectrum and a variant not confined to young females. Am J Surg Pathol 24:285-94, Sussman J, Rosai J. Lymph node metastasis as the initial manifestation of malignant mesothelioma. Report of six cases. Am J Surg Pathol 14: , Young RH, Scully RE. Differential diagnosis of ovarian tumors based primarily on their patterns and cell types. Semin Diagn Pathol 2001;18: , 2001

Today s Topics. Tumors of the Peritoneum in Women

Today s Topics. Tumors of the Peritoneum in Women Today s Topics Tumors of the Peritoneum in Women Charles Zaloudek, M.D. Department of Pathology 505 Parnassus Ave., M563 University of California, San Francisco San Francisco, CA USA charles.zaloudek@ucsf.edu

More information

Case of the. Month October, 2012

Case of the. Month October, 2012 Case of the Month October, 2012 Case The patient is a 47-year-old male with a 3-week history of abdominal pain. A CT scan of the abdomen revealed a suggestion of wall thickening at the tip of the appendix

More information

Pathology of the Female Peritoneum, Common and Uncommon Problems

Pathology of the Female Peritoneum, Common and Uncommon Problems Pathology of the Female Peritoneum, Common and Uncommon Problems An Update on Gynecologic Pathology Florence, Italy Anaís Malpica, M.D. Professor of Pathology Pathology of the Female Peritoneum Keratin

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied

More information

Malignant Peritoneal Mesothelioma in Women A Study of 75 Cases With Emphasis on Their Morphologic Spectrum and Differential Diagnosis

Malignant Peritoneal Mesothelioma in Women A Study of 75 Cases With Emphasis on Their Morphologic Spectrum and Differential Diagnosis Anatomic Pathology / MALIGNANT PERITONEAL MESOTHELIOMA IN WOMEN Malignant Peritoneal Mesothelioma in Women A Study of 75 Cases With Emphasis on Their Morphologic Spectrum and Differential Diagnosis Patricia

More information

Update on Mesothelioma

Update on Mesothelioma November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical

More information

Case presentation. Awatif Al-Nafussi

Case presentation. Awatif Al-Nafussi Case presentation Awatif Al-Nafussi Case History 49 year old DVT & small PE June 08, Pelvic mass Ca125 33 Laparotomy-TAHBSO, drainage of ascites Ovarian carcinoma Clinical diagnosis Multiple specimens

More information

Protocol applies to all primary borderline and malignant epithelial tumors, and malignant mesothelial neoplasms of the peritoneum.

Protocol applies to all primary borderline and malignant epithelial tumors, and malignant mesothelial neoplasms of the peritoneum. Peritoneum Protocol applies to all primary borderline and malignant epithelial tumors, and malignant mesothelial neoplasms of the peritoneum. Protocol revision date: January 2004 No AJCC/UICC staging system

More information

Diagnosis of Mesothelioma Pitfalls and Practical Information

Diagnosis of Mesothelioma Pitfalls and Practical Information Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com

More information

3-F. Pathology of Mesothelioma

3-F. Pathology of Mesothelioma 3-F. Pathology of Mesothelioma Kouki Inai Professor of Department of Pathology, Graduate School of Biomedical Science, Hiroshima University Introduction Mesothelioma is a peculiar type of malignancy, which

More information

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma

More information

Notice of Faculty Disclosure

Notice of Faculty Disclosure The Diagnosis of Malignant Mesothelioma Andrew Churg, MD Department of Pathology University of British Columbia Vancouver, BC, Canada achurg@mail.ubc.ca Notice of Faculty Disclosure In accordance with

More information

Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum

Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum Protocol applies to all primary borderline and malignant epithelial tumors and malignant mesothelial neoplasms of the

More information

The develpemental origin of mesothelium

The develpemental origin of mesothelium Mesothelioma Tallinn 14.12.06 Henrik Wolff Finnish Institute of Occupational Health The develpemental origin of mesothelium Mesodermal cavities (pleura, peritoneum and pericardium ) are lined with mesenchymal

More information

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD Victor E. Reuter, MD Memorial Sloan-Kettering Cancer Center reuterv@mskcc.org 66 th Annual Pathology Seminar California Society of Pathologists Short

More information

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT Dott. Francesco Pontieri (*) U.O. di Anatomia Patologica P.O. di Rossano (CS) Dott. Gian Franco Zannoni Anatomia Patologica Facoltà di Medicina e Chirurgia

More information

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH How to cite this article: DEBNATH S, MISRA V, SINGH PA, SINGH M. LOW GRADE CYSTIC MESOTHELIOMA OF RECTUS SHEATH.Journal of Clinical and Diagnostic Research [serial

More information

Diagnostic Challenge. Department of Pathology,

Diagnostic Challenge. Department of Pathology, Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland Oulu University Hospital

More information

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Introduction 3 cavities with the same embryologic origin the mesoderme Pleura Exudates Pleura Peritoneum Pericardium 22%

More information

Case presentation: Mesothelioma of the tunica vaginalis. Dr Ben Shepherd Pathology Queensland Princess Alexandra Hospital Brisbane

Case presentation: Mesothelioma of the tunica vaginalis. Dr Ben Shepherd Pathology Queensland Princess Alexandra Hospital Brisbane Case presentation: Mesothelioma of the tunica vaginalis Dr Ben Shepherd Pathology Queensland Princess Alexandra Hospital Brisbane A 76 year old man presented June 2011 with a 6 month history of painless

More information

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Outline. Workup for metastatic breast cancer. Metastatic breast cancer Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30

More information

Immunohistochemistry on cytology specimens from pleural and peritoneal fluid

Immunohistochemistry on cytology specimens from pleural and peritoneal fluid Immunohistochemistry on cytology specimens from pleural and peritoneal fluid Dr Naveena Singh Consultant Pathologist Bart health NHS Trust London United Kingdom Disclosures and Acknowledgements I have

More information

Effusions: Mesothelioma and Metastatic Cancers

Effusions: Mesothelioma and Metastatic Cancers Effusions: Mesothelioma and Metastatic Cancers Malignant Mesothelioma Incidence: 2,500 cases/year ~60-80% pts with pleural MM relationship with asbestos exposure Other risk factors: radiation, other carcinogens,

More information

Practical Effusion Cytology

Practical Effusion Cytology Practical Effusion Cytology A Community Pathologist s Approach to Immunocytochemistry in Body Fluid Cytology Emily E. Volk, MD William Beaumont Hospital Troy, MI College of American Pathologists 2004.

More information

A. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information.

A. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information. 5. PERICARDIUM Heart is encased by the pericardium which has a visceral layer (a) covering the heart and the parietal layer (b). In normal states it is thin, transparent and the myocardium can be seen

More information

Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas

Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger Immunohistochemistry in malignant mesotheliomas Françoise Thivolet-Béjui Groupement Hospitalier Est Lyon-Bron

More information

MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT

MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT Written by: Karyn Varley MS, SCT(ASCP) The donating laboratory would like to remain anonymous. PATIENT HISTORY 28 year old female Lived

More information

Primary malignant gonadal mesotheliomas and asbestos

Primary malignant gonadal mesotheliomas and asbestos Histopathology 2000, 37, 150±159 Primary malignant gonadal mesotheliomas and asbestos R L Attanoos & A R Gibbs Department of Histopathology, University Hospital of Wales and Llandough Hospital, Cardiff,

More information

How To Diagnose And Treat A Tumour In An Effusion

How To Diagnose And Treat A Tumour In An Effusion Effusions of the Serous Cavities Annika Dejmek Professor/Consultant in Cytopathology Clinical Pathology; Department of Laboratory Medicine, Malmö, Lund University 5th EFCS Tutorial Trondheim 2012 Pleura

More information

INFLAMMATORY PLEURAL EFFUSION

INFLAMMATORY PLEURAL EFFUSION PLEURA- LESIONS LESIONS OF PLEURA Primary Intra pleural bacterial infections Neoplasm (mesothelioma) Secondary A complication of some underlying disease PLEURAL EFFUSION Common manifestation of both primary

More information

Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell!

Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! Disclosures Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! No Relevant Financial Relationships with Commercial Interests Syed Z. Ali, M.D. Syed Z. Ali, M.D. Associate Professor of

More information

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours Pleura Visceral pleura covers lungs and extends into fissures Parietal pleura limits mediastinum and covers dome of diaphragm and inner aspect of chest wall. Two layers between them (pleural cavity) contains

More information

Cytopathology Case Presentation #8

Cytopathology Case Presentation #8 Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents

More information

Something Old, Something New.

Something Old, Something New. Something Old, Something New. Michelle A. Fajardo, D.O. Loma Linda University Medical Center Clinical Presentation 6 year old boy, presented with hematuria Renal mass demonstrated by ultrasound & CT scan

More information

How To Test For Cancer

How To Test For Cancer Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! Effusion = Confusion Syed Z. Ali, M.D. Professor of Pathology and Radiology The Johns Hopkins Hospital Baltimore, Maryland Diagnostic

More information

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA Papillary carcinoma is the most common of thyroid malignancies and occurs in all age groups but particularly in women under 45 years of age. There is a high rate of cervical metastatic disease and yet

More information

Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.

Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion. Seattle Montreal IAP September 2006 Case Presentations Allen M. Gown, M.D. Medical Director and Chief Pathologist PhenoPath Laboratories Clinical Professor of Pathology University of British Columbia Case

More information

Cystic mesothelioma of the peritoneum

Cystic mesothelioma of the peritoneum Pathology Feature William R. Hart, M.D. Section Editor Cystic mesothelioma of the peritoneum Report of a case with multiple recurrences and review of the literature 1 Janet M. Miles, M.D. William R. Hart,

More information

J of Evidence Based Med & Hlthcare, pissn- 2349-2562, eissn- 2349-2570/ Vol. 2/Issue 33/Aug. 17, 2015 Page 5063

J of Evidence Based Med & Hlthcare, pissn- 2349-2562, eissn- 2349-2570/ Vol. 2/Issue 33/Aug. 17, 2015 Page 5063 PERITONEAL MALIGNANT MESOTHELIOMA: A RARE S. R. Dhamotharan 1, S. Shanthi Nirmala 2, F. Celine Foustina Mary 3, M. Arul Raj Kumar 4, R. Vinothprabhu 5 HOW TO CITE THIS ARTICLE: S. R. Dhamotharan, S. Shanthi

More information

Video Microscopy Tutorial 5

Video Microscopy Tutorial 5 Video Microscopy Tutorial 5 Lool Alikes in Effusion Cytology:Review of Diagnostic Challenges Claire Michael, MD There are no disclosures necessary. Look-Alikes in Effusion Cytology: Review of Diagnostic

More information

Ovarian tumors Ancillary methods

Ovarian tumors Ancillary methods Ovarian tumors Ancillary methods Ovarian tumor course Oslo, 24-25/11/14 Prof. Ben Davidson, MD PhD Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway Division of

More information

Diseases of peritoneum Lect. Al Qassim University, Faculty of Medicine Phase II Year III, CMD 332 Pathology Department 31-32

Diseases of peritoneum Lect. Al Qassim University, Faculty of Medicine Phase II Year III, CMD 332 Pathology Department 31-32 Diseases of peritoneum Lect Al Qassim University, Faculty of Medicine Phase II Year III, CMD 332 Pathology Department 31-32 Describe the etiology, pathogenesis and types of peritonitis Define ascites and

More information

HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download

HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download AP2003R1 http://hkcpath.org. Correspondence: pkhui@ha.org.hk 1of 10 07/08/2003 HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download AP141 Bone Marrow: Metastatic Carcinoma from

More information

The menstrual cycle Hypophysis

The menstrual cycle Hypophysis Normal endometrium Tumors of the uterine corpus by MB The endometrium comprises the zona functionalis zf (superficial two thirds) ) and the zona basalis zb (deep one third) The zf responds to hormonal

More information

Ovarian mucinous lesions. Ovarian mucinous lesions: Common diagnostic dilemmas. Ovarian mucinous lesions: problematic issues

Ovarian mucinous lesions. Ovarian mucinous lesions: Common diagnostic dilemmas. Ovarian mucinous lesions: problematic issues Ovarian mucinous lesions Ovarian mucinous lesions: Common diagnostic dilemmas Karuna Garg, MD University of California San Francisco Intestinal or usual type Seromucinous (Endocervical mucinous or Mullerian

More information

Surgical Staging of Endometrial Cancer

Surgical Staging of Endometrial Cancer Surgical Staging of Endometrial Cancer I. Endometrial Cancer Surgical Staging Overview Uterine cancer types: carcinomas type I and type II, sarcomas, carcinosarcomas Hysterectomy with BSO Surgical Staging

More information

A Cytokeratin- and Calretinin-negative Staining Sarcomatoid Malignant Mesothelioma

A Cytokeratin- and Calretinin-negative Staining Sarcomatoid Malignant Mesothelioma A Cytokeratin- and Calretinin-negative Staining Sarcomatoid Malignant Mesothelioma MICHAEL G. HURTUK and MICHELE CARBONE Cardinal Bernadin Cancer Center, Cancer Immunology Program, Department of Pathology,

More information

R-16: Chronic nonspecific cervisit

R-16: Chronic nonspecific cervisit R-16: Chronic nonspecific cervisit Ectoservikal squamous epithelium Endoservical columnar epithelium Dilated cystic endoservical glands lymphoplasmocytes R18:Squamous cell carcinoma insitu Neoplastic epithelium

More information

Diagnosis of Synovial Sarcoma of the Pleura and Differentiation from Malignant Mesothelioma

Diagnosis of Synovial Sarcoma of the Pleura and Differentiation from Malignant Mesothelioma 36 Diagnosis of Synovial Sarcoma of the Pleura and Differentiation from Malignant Mesothelioma Amy Powers and Michele Carbone Synovial sarcomas (SSs) are soft tissue tumors that occur primarily in adolescents

More information

Case based applications part III

Case based applications part III Case based applications part III Los Angeles Society Of Pathologists January 25, 2014 Sanja Dacic, MD, PhD University of Pittsburgh Medical Center 1 CASE 1 A 44-year-old woman with multiple lung nodules.

More information

Malignant mesothelioma of the pleura: relation

Malignant mesothelioma of the pleura: relation Thorax 1982;37:810-815 Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour MR LAW, MARGARET E HODSON, BE HEARD From the Cardiothoracic Institute and Brompton

More information

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD Department of Pathology University of Szeged, Hungary ISUP Vancouver Classification of Renal Neoplasia Am J Surg Pathol 37:14691489, 2013 13 histologic

More information

Histopathology of Major Salivary Gland Neoplasms

Histopathology of Major Salivary Gland Neoplasms Histopathology of Major Salivary Gland Neoplasms Sam J. Cunningham, MD, PhD Faculty Advisor: Shawn D. Newlands, MD, PhD Faculty Advisor: David C. Teller, MD The University of Texas Medical Branch, Department

More information

Recommendations for the Reporting of Pleural Mesothelioma

Recommendations for the Reporting of Pleural Mesothelioma Recommendations for the Reporting of Pleural Mesothelioma Association of Directors of Anatomic and Surgical Pathology * DOI: 10.1309/6A30YQHBMTHEJTEM It has been evident for decades that pathology reports

More information

Nilesh P. Patel, MD, 1 Cullen A. Taylor, MD, 1* Edward A. Levine, MD, 2 Jacqueline K. Trupiano, MD, 1* and Kim R. Geisinger, MD 1.

Nilesh P. Patel, MD, 1 Cullen A. Taylor, MD, 1* Edward A. Levine, MD, 2 Jacqueline K. Trupiano, MD, 1* and Kim R. Geisinger, MD 1. Anatomic Pathology / PRIMARY PERITONEAL MESOTHELIOMA Cytomorphologic Features of Primary Peritoneal Mesothelioma in Effusion, Washing, and Fine-Needle Aspiration Biopsy Specimens Examination of 49 Cases

More information

Abstract. Introduction. Material and Methods

Abstract. Introduction. Material and Methods Original Article Expression of Mesothelial Markers in Malignant Mesotheliomas: an Immunohistochemical Evaluation of 173 Cases I.N. Soomro, R. Oliveira*, J. Ronan, Z. R. Chaudry, J. Johnson Department of

More information

From the Archives of the AFIP

From the Archives of the AFIP Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. AFIP ARCHIVES 583

More information

The Use of Immunohistochemistry to Distinguish Reactive Mesothelial Cells From Malignant Mesothelioma in Cytologic Effusions

The Use of Immunohistochemistry to Distinguish Reactive Mesothelial Cells From Malignant Mesothelioma in Cytologic Effusions The Use of Immunohistochemistry to Distinguish Reactive Mesothelial Cells From Malignant Mesothelioma in Cytologic Effusions Farnaz Hasteh, MD 1 ; Grace Y. Lin, MD, PhD 1 ; Noel Weidner, MD 1 ; and Claire

More information

Histologic Classification and Differential Diagnosis of Mesothelioma

Histologic Classification and Differential Diagnosis of Mesothelioma THE YALE JOURNAL OF BIOLOGY AND MEDICINE 54 (1981), 173-180 Histologic Classification and Differential Diagnosis of Mesothelioma DARRYL CARTER, M.D. Department of Pathology, Yale University School of Medicine,

More information

20 Diagnostic Cytopathology, Vol 36, No 1 ' 2007 WILEY-LISS, INC.

20 Diagnostic Cytopathology, Vol 36, No 1 ' 2007 WILEY-LISS, INC. Utility of WT-1, p63, MOC31, Mesothelin, and Cytokeratin (K903 and CK5/6) Immunostains in Differentiating Adenocarcinoma, Squamous Cell Carcinoma, and Malignant Mesothelioma in Effusions Robert T. Pu,

More information

Emerging Subtypes in Renal Cancer. Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd.

Emerging Subtypes in Renal Cancer. Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd. Emerging Subtypes in Renal Cancer Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd.edu Some General Comments Fuhrman nuclear grading clear cell

More information

Case Report Malignant Mesothelioma Mimicking Invasive Mammary Carcinoma in a Male Breast

Case Report Malignant Mesothelioma Mimicking Invasive Mammary Carcinoma in a Male Breast Case Reports in Oncological Medicine Volume 2015, Article ID 298523, 4 pages http://dx.doi.org/10.1155/2015/298523 Case Report Malignant Mesothelioma Mimicking Invasive Mammary Carcinoma in a Male Breast

More information

Carcinosarcoma of the Ovary

Carcinosarcoma of the Ovary Carcinosarcoma of the Ovary A Rare Finding Presented By: Kathryn Kiely Anisa I. Kanbour School of Cytotechnology of the University of Pittsburgh Medical Center Pittsburgh, PA Patient History 55 year old

More information

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred

More information

Male. Female. Death rates from lung cancer in USA

Male. Female. Death rates from lung cancer in USA Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita

More information

Fine Needle Aspiration Cytologic Features of Well-Differentiated Papillary Mesothelioma in the Pleura

Fine Needle Aspiration Cytologic Features of Well-Differentiated Papillary Mesothelioma in the Pleura The Korean Journal of Pathology 2009; 43: 583-8 DOI: 10.4132/KoreanJPathol.2009.43.6.583 Fine Needle Aspiration Cytologic Features of Well-Differentiated Papillary Mesothelioma in the Pleura - A Case Report

More information

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE HISTORY 52Y MALE RIGHT RADICAL NEPHERECTOMY Case of right renal mass with IVC thrombus. History of surgery and RT for right occipital

More information

MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER

MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER Renal tumours WHO 4 MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER Molecular differential pathology of renal cell tumours G. KOVACS A CLASSIFICATION BASED ON UNDERSTANDING THE GENETIC

More information

More than 2,500 people are diagnosed with mesothelioma in the UK each year.

More than 2,500 people are diagnosed with mesothelioma in the UK each year. This information is an extract from the booklet Understanding mesothelioma. You may find the full booklet helpful. We can send you a free copy see page 5. Contents Introduction Pleural mesothelioma Peritoneal

More information

Role of immunohistochemistry

Role of immunohistochemistry Tumors of serous membranes of difficult diagnosis: Dr. Hector Battifora Role of immunohistochemistry Abstract: The most common differential diagnosis of tumors involving serosal surfaces is adenocarcinoma

More information

ALTHOUGH excellent accounts have been published in recent years of

ALTHOUGH excellent accounts have been published in recent years of THE EXFOLIATIVE CYTOLOGY OF DIFFUSE MALIGNANT MESOTHELIOMA BERNARD NAYLOR Department of Pathology, University of Michigan, Ann Arbor, Michigan, U.S.A. PLATE~ LXXXVI-XCI ALTHOUGH excellent accounts have

More information

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE Ryan Granger University of Rhode Island Cytotechnology program May 2, 2015 ASCT Annual Meeting Nashville, Tennessee DESMOPLASTIC SMALL ROUND

More information

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause. Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic

More information

A 70-year old Man with Pleural Effusion

A 70-year old Man with Pleural Effusion Mesothelioma Diagnosis: Pitfalls and Latest Updates S Klebe and DW Henderson Recommendations Indisputable malignant cells on cytomorphological criteria which demonstrate a mesothelial phenotype, which

More information

Gynecology Abnormal Physiology of the ovaries. Simple Cystic Masses

Gynecology Abnormal Physiology of the ovaries. Simple Cystic Masses Gynecology Abnormal Physiology of the ovaries (Effective February 2007) pediatric, reproductive, and perimenopausal/postmenopausal (24-28 %) Simple Cystic Masses ovary s function is to mature oocytes until

More information

Frequently Asked Questions About Ovarian Cancer

Frequently Asked Questions About Ovarian Cancer Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues

More information

Benign Ovarian Masses

Benign Ovarian Masses Benign Ovarian Masses Anthony Hanbidge Learning Objectives Describe technique for assessment of ovarian masses Explain importance of transvaginal scan List the common benign masses Specify distinguishing

More information

Diagnostic Pitfalls In Thoracic Tumors

Diagnostic Pitfalls In Thoracic Tumors 1376 Diagnostic Pitfalls In Thoracic Tumors Neda Kalhor, MD Cesar A. Moran, MD, FASCP WEEKEND OF PATHOLOGY AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 33 W Monroe Ste 1600 Chicago, IL 60603 Program Content

More information

ISOLATED PANCREATIC METASTASIS OF A MALIGNANT PLEURAL MESOTHELIOMA

ISOLATED PANCREATIC METASTASIS OF A MALIGNANT PLEURAL MESOTHELIOMA ISOLATED PANCREATIC METASTASIS OF A MALIGNANT PLEURAL MESOTHELIOMA Yi-Ting Lin, 1 Bing-Shiun Wu, 2 Sheau-Fang Yang, 3 and Huang-Chi Chen 4 Departments of 1 Family Medicine, 2 Internal Medicine, and 3 Pathology,

More information

Diagnosis and treatment of benign multicystic peritoneal mesothelioma

Diagnosis and treatment of benign multicystic peritoneal mesothelioma Online Submissions: http://www.wjgnet.com/esps/ wjg@wjgnet.com doi:10.3748/wjg.v19.i39.6689 World J Gastroenterol 2013 October 21; 19(39): 6689-6692 ISSN 1007-9327 (print) ISSN 2219-2840 (online) CASE

More information

VM104 TUMORS OF THE PLEURA AND MEDIASTINUM

VM104 TUMORS OF THE PLEURA AND MEDIASTINUM VM104 TUMORS OF THE PLEURA AND MEDIASTINUM Saul Suster, MD Ohio State University Hospital Columbus, OH University of Texas MD Anderson Cancer Center Houston, Texas September 19, 2004 Page 2 of 26 THYMOMAS

More information

Lymphohistiocytoid Mesothelioma An Often Misdiagnosed Variant of Sarcomatoid Malignant Mesothelioma

Lymphohistiocytoid Mesothelioma An Often Misdiagnosed Variant of Sarcomatoid Malignant Mesothelioma Anatomic Pathology / LYMPHOHISTIOCYTOID MESOTHELIOMA Lymphohistiocytoid Mesothelioma An Often Misdiagnosed Variant of Sarcomatoid Malignant Mesothelioma Hasan S. Khalidi, MD, 1 L. Jeffrey Medeiros, MD,

More information

Primary -Benign - Malignant Secondary

Primary -Benign - Malignant Secondary TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low

More information

Cardiac Masses and Tumors

Cardiac Masses and Tumors Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:

More information

Distinguishing benign from malignant mesothelial

Distinguishing benign from malignant mesothelial ORIGINAL ARTICLE IMP3 and GLUT-1 Immunohistochemistry for Distinguishing Benign From Malignant Mesothelial Proliferations Anna F. Lee, MDCM, PhD,*w Allen M. Gown, MD,wz and Andrew Churg, MD*w Abstract:

More information

POSTMENOPAUSAL ASSESS AND WHAT TO DO

POSTMENOPAUSAL ASSESS AND WHAT TO DO POSTMENOPAUSAL OVARIAN CYSTS:HOW TO ASSESS AND WHAT TO DO Steven R. Goldstein, MD Professor of Obstetrics and Gynecology Director of Gynecologic Ultrasound Co-Director, Bone Densitometry New York University

More information

Correspondence. A migrating granuloma

Correspondence. A migrating granuloma Histopathology 2003, 43, 499 505 Correspondence A migrating granuloma Sir: Granulomas both of the foreign body and delayed hypersensitivity (immune) type are usually part of tissue-based inflammatory processes.

More information

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin A Acantholytic squamous cell carcinoma vs epithelioid angiosarcoma, 56-57 Acinic cell carcinoma of pancreas, 76-77 vs ductal adenocarcinoma, 74-75 vs islet cell tumor, 78-81 Adenomatoid tumor vs hemangioma,

More information

ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3

ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3 ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3 HOW TO CITE THIS ARTICLE: Gorantla Sambasivarao, Namballa Usharani,

More information

The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin

The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin Anatomic Pathology / TTF-1 IN CYTOLOGY OF BODY FLUIDS The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin Jonathan L. Hecht, MD,

More information

Case Report Epithelioid malignant mesothelioma presenting with features of gastric tumor in a child

Case Report Epithelioid malignant mesothelioma presenting with features of gastric tumor in a child Int J Clin Exp Pathol 2014;7(5):2636-2640 www.ijcep.com /ISSN:1936-2625/IJCEP0000187 Case Report Epithelioid malignant mesothelioma presenting with features of gastric tumor in a child Qihan You 1, Jing

More information

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS The evolving pathology of solitary fibrous tumours Luciane Dreher Irion MREH / CMFT / NSOPS Historical review Haemangiopericytoma (HPC) first described primarily as a soft tissue vascular tumour of pericytic

More information

p53 Expression in a Malignant Mesothelioma Patient during Seven-Year Follow-up

p53 Expression in a Malignant Mesothelioma Patient during Seven-Year Follow-up CASE REPORT http://dx.doi.org/10.4046/trd.2014.76.6.284 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2014;76:284-288 p53 Expression in a Malignant Mesothelioma Patient during Seven-Year Follow-up

More information

Histopathology of Colorectal Cancer after Neoadjuvant Chemoradiation Therapy

Histopathology of Colorectal Cancer after Neoadjuvant Chemoradiation Therapy The Open Pathology Journal, 2009, 3, 91-98 91 Open Access Histopathology of Colorectal Cancer after Neoadjuvant Chemoradiation Therapy Maura O Neil * and Ivan Damjanov Department of Pathology and Laboratory

More information

Malignant Mesothelioma in Body Fluids - with Special Reference to Differential Diagnosis from Metastatic Adenocarcinoma -

Malignant Mesothelioma in Body Fluids - with Special Reference to Differential Diagnosis from Metastatic Adenocarcinoma - The Korean Journal of Pathology 2009; 43: 458-66 DOI: 10.4132/KoreanJPathol.2009.43.5.458 Malignant Mesothelioma in Body Fluids - with Special Reference to Differential Diagnosis from Metastatic Adenocarcinoma

More information

Cytology of Malignant Mesothelioma

Cytology of Malignant Mesothelioma 31 Cytology of Malignant Mesothelioma Richard M. DeMay Because patients with mesotheliomas frequently present with effusions, cytologic examination of the effusion fluid may be the first diagnostic study.

More information

Clinicopathological Study on Malignant Pleural Mesotheliomas

Clinicopathological Study on Malignant Pleural Mesotheliomas Table of Contents Clinicopathological Study on Malignant Pleural Mesotheliomas PL-4-03 Kenzo Hiroshima Kenzo Hiroshima 1, Akira Iyota 1, Kiyoshi Sibuya 1, Toshikazu Yusa 2, Takehiko Fujisawa 1 and Yukio

More information

Cytology of Effusion Fluids. Cytology of Effusion Fluids. Types of Effusion Fluids. Anatomy. Causes of Effusions. Sampling of Effusion Fluids

Cytology of Effusion Fluids. Cytology of Effusion Fluids. Types of Effusion Fluids. Anatomy. Causes of Effusions. Sampling of Effusion Fluids Cytology of Effusion Fluids John W. Wong, MD, FRCPC Sunnybrook Health Sciences Centre Assistant Professor, Laboratory Medicine and Pathobiology Faculty of Medicine, University of Toronto November 10, 2012

More information

Clinical Presentation and Natural History of Mesothelioma: Abdominal

Clinical Presentation and Natural History of Mesothelioma: Abdominal 25 Clinical Presentation and Natural History of Mesothelioma: Abdominal Claire F. Verschraegen, Charles R. Key, and Raffit Hassan Epidemiology and Etiology The Surveillance, Epidemiology, and End Results

More information